BOSTON, July 31,
2024 /PRNewswire/ -- O'Ryan.Health, a leader in
at-home pediatric healthcare innovation, today announced it has
become the first US company to launch two, parent-led observational
studies "The Healthy Kids Study" and "The JDM Study," involving the
in-home collection of pediatric blood from children. Juvenile
Dermatomyositis (JDM) is an ultra-rare pediatric autoimmune
disorder. These studies, made possible through a partnership with
YourBio Health, a pioneer in capillary blood sampling, allow
parents to safely and efficiently sample their children's blood
without having to travel to a medical facility.
"Today marks 'one giant leap,' for pediatric healthcare, opening
doors to those who have previously been overlooked in the world of
health research," said Dr. Tim
Coleman, COO and Co-founder, O'Ryan.Health. "We understand
the challenges families face with distant research sites, which is
why we've pioneered a method with YourBio Health's TAP devices that
allows for blood sample collection right from the safety and
comfort of home."
The institutional review board approved study involves healthy
children and children with a JDM diagnosis. Capillary blood is
drawn on a predetermined schedule using virtually painless TAP
Micro devices. Guided by animated Superhero Scientists and comic
book "mission reports" of their results, children take an active
role in their healthcare journey and learn about their immune
health.
"We are thrilled to partner with O'Ryan.Health in pioneering
at-home, decentralized studies for children with JMD
and healthy children alike," said Paul
Owen, President and CEO, YourBio Health. "Through
O'Ryan.Health's approach with TAP devices, more families and
children can access and join groundbreaking research."
About YourBio Health
YourBio Health is a Flagship Pioneering portfolio company that
invented 'Touch-Activated Phlebotomy' (TAP) for virtually painless
capillary blood collection. Backed by the latest science and
certified central laboratories, YourBio Health seeks to
revolutionize and humanize the blood collection process serving
clinical trials, diagnostic and wellness applications.
About O'Ryan.Health
O'Ryan.Health is introducing a pioneering initiative aimed at
transforming pediatric autoimmune research and becoming the trusted
brand in at-home pediatric blood sampling. O'Ryan.Health envisions
a future where pediatric autoimmune diseases are not just managed
but potentially cured and aims to create lasting value in the
pediatric at-home blood testing market.
For more information or to enroll in O'Ryan.Health's study
please visit: O'Ryan.Health.
Web: https://oryan.health/
Instagram: ORyan_Therapeutics
View original content to download
multimedia:https://www.prnewswire.com/news-releases/oryanhealth-launches-groundbreaking-parent-led-pediatric-studies-utilizing-yourbio-healths-tap-capillary-blood-sampling-devices-302210495.html
SOURCE YourBio Health; O’Ryan Therapeutics, Inc.